Mutated EGFR-IN-1 is a research compound designed as an inhibitor of mutated epidermal growth factor receptor (EGFR). It is primarily used in laboratory studies to investigate EGFR mutations and their role in cellular signaling pathways.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1421372-66-8
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-1,4-benzenediamine
pharmaceutical intermediate
N-Ethyl-D-glucamine
pharmaceutical intermediate
Entecavir
active pharmaceutical ingredient
2-Amino-1,9-dihydro-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylene cyclopentyl)-6H-purine-6-one
antiviral active pharmaceutical ingredient
ADEFOVIR DIPIVOXIL
antiviral prodrug substance
Osimertinib
active pharmaceutical ingredient
Osimertinib mesylate
active pharmaceutical ingredient
N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
pharmaceutical intermediate for osimertinib
1-N-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine
HTNTZPBKKCORTP-UHFFFAOYSA-N
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)N)N(C)CCN(C)C)OC